AVALO THERAPEUTICS INC's ticker is and the CUSIP is 05338F207. A total of 33 filers reported holding AVALO THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $700,000 | – | 400,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| VR Adviser, LLC | 1,000,000 | $1,750,000 | 0.34% |
| GREAT POINT PARTNERS LLC | 474,639 | $830,618 | 0.16% |
| ARMISTICE CAPITAL, LLC | 4,415,000 | $7,726,250 | 0.11% |
| Nantahala Capital Management | 808,844 | $1,415,477 | 0.11% |
| Monashee Investment Management LLC | 60,000 | $105,000 | 0.03% |
| BRAIDWELL LP | 247,254 | $432,695 | 0.01% |
| Point72 Asset Management, L.P. | 1,100,737 | $1,926,290 | 0.01% |
| Alyeska Investment Group, L.P. | 400,000 | $700,000 | 0.01% |
| Maven Securities LTD | 92,937 | $162,640 | 0.00% |
| VANGUARD GROUP INC | 222,073 | $388,628 | 0.00% |